intermediate stroke risk
Showing 1 - 25 of >10,000
Atrial Fibrillation Patients With Intermediate Stroke Risk Trial in Seoul (Anticoagulation group(Apixaban group))
Recruiting
- Atrial Fibrillation Patients With Intermediate Stroke Risk
- Anticoagulation group(Apixaban group)
-
Seoul, Korea, Republic ofSeverance Cardiovascular Hospital Yonsei University
Aug 11, 2020
Pulmonary Embolism Trial in Milano (ultrasound-assisted, catheter-directed thrombolysis)
Recruiting
- Pulmonary Embolism
- ultrasound-assisted, catheter-directed thrombolysis
-
Milano, Italia, ItalyASST GOM Niguarda
Nov 21, 2023
Pulmonary Embolism Subacute Massive Trial (Mechanical embolectomy: by hydromechanical defragmentation by pigtail, Suction
Not yet recruiting
- Pulmonary Embolism Subacute Massive
- Mechanical embolectomy: by hydromechanical defragmentation by pigtail
- Suction embolectomy by the Penumbra Indigo aspiration system
- (no location specified)
Nov 9, 2022
Intermediate to High-risk Asymptomatic Sportsmen With Exercise
Completed
- Electrocardiography
- Screening stress test on a bicycle ergometer (usual practise)
-
Saint-Étienne, FranceCentre Hospitalier de Saint-Etienne
Sep 6, 2023
Anal Squamous Cell Carcinoma Trial (Radiotherapy - Low risk group, Radiotherapy - Standard risk group, Radiotherapy -
Not yet recruiting
- Anal Squamous Cell Carcinoma
- Radiotherapy - Low risk group
- +3 more
- (no location specified)
Sep 18, 2023
Prostate Cancer Trial in Guangzhou ([18F]Florastamin Injection)
Recruiting
- Prostate Cancer
- [18F]Florastamin Injection
-
Guangzhou, ChinaSun Yat-sen University Cancer Center
Aug 21, 2023
Chest Pain, Acute Coronary Syndrome, Coronary Artery Disease Trial in Stockholm (Coronary computed tomopraphic angiography)
Recruiting
- Chest Pain
- +2 more
- Coronary computed tomopraphic angiography
-
Stockholm, SwedenDanderyd Hospital
Aug 16, 2022
Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,
Not yet recruiting
- Localized Prostate Carcinoma
- +3 more
- Degarelix
- MRI-guided transurethral ultrasound ablation (TULSA)
-
Turku, Southwest Finland, FinlandTurku University Hospital
Jun 14, 2023
All Conditions Requiring Non-cardiac Surgery Trial (Training)
Not yet recruiting
- All Conditions Requiring Non-cardiac Surgery
- Training
- (no location specified)
Oct 30, 2023
Prostate Cancer Trial (Piflufolastat F 18 Intravenous Solution [PYLARIFY])
Not yet recruiting
- Prostate Cancer
- Piflufolastat F 18 Intravenous Solution [PYLARIFY]
- (no location specified)
Oct 3, 2023
Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])
Recruiting
- Pre-fibrotic Myelofibrosis
- Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
-
Taipei, Taiwan, 100, TaiwanNational Taiwan University Hospital
Feb 7, 2023
Prostatic Cancer Trial (High Dose Brachytherapy, Stereostatic Body Radiation Therapy)
Not yet recruiting
- Prostatic Cancer
- High Dose Brachytherapy
- Stereostatic Body Radiation Therapy
- (no location specified)
Mar 3, 2023
Screening CEDM in Intermediate and High-Risk Patient Populations
Completed
- Breast Cancer
- Contrast Enhanced Digital Mammography
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 18, 2023
Prostate Cancer Trial in New Haven (Relugolix 120 MG [Orgovyx], SBRT standard of care radiotherapy treatment)
Not yet recruiting
- Prostate Cancer
- Relugolix 120 MG [Orgovyx]
- SBRT standard of care radiotherapy treatment
-
New Haven, ConnecticutYale Cancer Center
Oct 26, 2023
Stroke Trial (CHAMPS)
Not yet recruiting
- Stroke
- CHAMPS
- (no location specified)
Sep 27, 2023
Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer Trial (Cretostimogene Grenadenorepvec,
Not yet recruiting
- Non Muscle Invasive Bladder Cancer
- +3 more
- Cretostimogene Grenadenorepvec
- n-dodecyl-B-D-maltoside
- (no location specified)
Oct 30, 2023
After Stroke and Initial Intervention: A fNIRs Study
Recruiting
- Stroke
-
Chongqing, ChinaDepartment of Rehabilitation Medicine, the First Affiliated Hosp
Sep 28, 2023
Pulmonary Embolism Trial in Prague (Thrombolytic, Standard anticoagulation)
Not yet recruiting
- Pulmonary Embolism
- Thrombolytic
- Standard anticoagulation
-
Prague, CzechiaUniversity Hospital Kralovske Vinohrady
Aug 5, 2022
Myelofibrosis Trial in Hangzhou (Jaktinib, Placebo to match Hydroxycarbamide, Hydroxycarbamide Tablets)
Recruiting
- Myelofibrosis
- Jaktinib
- +3 more
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 28, 2022
Breast Cancer Trial in Rozzano (external beams radiotherapy, brachytherapy)
Recruiting
- Breast Cancer
- external beams radiotherapy
- brachytherapy
-
Rozzano, Milano, ItalyIRCCS Istituto Clinico Humanitas
Jan 13, 2023
High Risk of Stroke Trial in Hangzhou (Usual Diet advice, ORIENT diet intervention)
Not yet recruiting
- High Risk of Stroke
- Usual Diet advice
- ORIENT diet intervention
-
Hangzhou, Zhejiang, ChinaSecond Affilated Hospital of Zhejiang University, School of Medi
Oct 19, 2023
Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)
Not yet recruiting
- Diffuse Large B-cell Lymphoma
- Mitoxantrone hydrochloride liposome injection
- +4 more
-
Changchun, Jilin, ChinaThe First Bethune Hospital of Jilin University
Aug 15, 2023
Prostate Cancer Trial in Chapel Hill (68Ga-HBED-CC-PSMA)
Recruiting
- Prostate Cancer
-
Chapel Hill, North CarolinaUniversity of North Carolina - Chapel Hill
Jan 31, 2023